- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ECL: 1-[(2R)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole(Non-covalent)
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.2: 18 residues within 4Å:- Chain A: L.332, I.335, Y.336, Y.339, V.391, I.394, G.395, I.398, I.399, V.402, E.403, G.423, F.425, H.426, I.429, Y.467, R.470, M.603
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:L.332, A:L.332, A:I.335, A:Y.336, A:Y.339, A:Y.339, A:V.391, A:I.394, A:I.398, A:I.399, A:V.402, A:F.425, A:I.429, A:Y.467, A:Y.467
- Hydrogen bonds: A:F.425
- Salt bridges: A:H.426, A:H.426, A:R.470
Y01.3: 20 residues within 4Å:- Chain A: P.424, F.425, L.428, S.455, F.456, V.459, L.460, C.463, R.470, T.479, I.480, I.482, Q.483, I.486, Q.596
- Chain B: M.554, I.557, T.558, A.561, I.565
16 PLIP interactions:13 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:P.424, A:F.425, A:L.428, A:F.456, A:F.456, A:V.459, A:V.459, A:I.482, A:Q.483, A:I.486, B:I.557, B:A.561, B:I.565
- Hydrogen bonds: A:T.479, A:Q.596
- Salt bridges: A:R.470
Y01.4: 11 residues within 4Å:- Chain A: C.494, M.497, P.527, M.528, L.530, F.531, F.534
- Chain B: S.556, A.560, I.564
- Ligands: POV.6
7 PLIP interactions:2 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:A.560, B:I.564, A:L.530, A:F.531, A:F.531, A:F.534, A:F.534
Y01.12: 18 residues within 4Å:- Chain B: L.332, I.335, Y.336, Y.339, V.391, I.394, G.395, I.398, I.399, V.402, E.403, G.423, F.425, H.426, I.429, Y.467, R.470, M.603
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:L.332, B:L.332, B:I.335, B:Y.336, B:Y.339, B:Y.339, B:V.391, B:I.394, B:I.398, B:I.399, B:V.402, B:F.425, B:I.429, B:Y.467, B:Y.467
- Hydrogen bonds: B:F.425
- Salt bridges: B:H.426, B:H.426, B:R.470
Y01.13: 20 residues within 4Å:- Chain B: P.424, F.425, L.428, S.455, F.456, V.459, L.460, C.463, R.470, T.479, I.480, I.482, Q.483, I.486, Q.596
- Chain C: M.554, I.557, T.558, A.561, I.565
15 PLIP interactions:12 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:F.425, B:L.428, B:F.456, B:F.456, B:V.459, B:V.459, B:I.482, B:Q.483, B:I.486, C:I.557, C:A.561, C:I.565
- Hydrogen bonds: B:T.479, B:Q.596
- Salt bridges: B:R.470
Y01.14: 11 residues within 4Å:- Chain B: C.494, M.497, P.527, M.528, L.530, F.531, F.534
- Chain C: S.556, A.560, I.564
- Ligands: POV.16
7 PLIP interactions:2 interactions with chain C, 5 interactions with chain B- Hydrophobic interactions: C:A.560, C:I.564, B:L.530, B:F.531, B:F.531, B:F.534, B:F.534
Y01.20: 18 residues within 4Å:- Chain C: L.332, I.335, Y.336, Y.339, V.391, I.394, G.395, I.398, I.399, V.402, E.403, G.423, F.425, H.426, I.429, Y.467, R.470, M.603
19 PLIP interactions:19 interactions with chain C- Hydrophobic interactions: C:L.332, C:L.332, C:I.335, C:Y.336, C:Y.339, C:Y.339, C:V.391, C:I.394, C:I.398, C:I.399, C:V.402, C:F.425, C:I.429, C:Y.467, C:Y.467
- Hydrogen bonds: C:F.425
- Salt bridges: C:H.426, C:H.426, C:R.470
Y01.21: 20 residues within 4Å:- Chain C: P.424, F.425, L.428, S.455, F.456, V.459, L.460, C.463, R.470, T.479, I.480, I.482, Q.483, I.486, Q.596
- Chain D: M.554, I.557, T.558, A.561, I.565
16 PLIP interactions:13 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:P.424, C:F.425, C:L.428, C:F.456, C:F.456, C:V.459, C:V.459, C:I.482, C:Q.483, C:I.486, D:I.557, D:A.561, D:I.565
- Hydrogen bonds: C:T.479, C:Q.596
- Salt bridges: C:R.470
Y01.22: 11 residues within 4Å:- Chain C: C.494, M.497, P.527, M.528, L.530, F.531, F.534
- Chain D: S.556, A.560, I.564
- Ligands: POV.24
7 PLIP interactions:2 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:A.560, D:I.564, C:L.530, C:F.531, C:F.531, C:F.534, C:F.534
Y01.29: 18 residues within 4Å:- Chain D: L.332, I.335, Y.336, Y.339, V.391, I.394, G.395, I.398, I.399, V.402, E.403, G.423, F.425, H.426, I.429, Y.467, R.470, M.603
19 PLIP interactions:19 interactions with chain D- Hydrophobic interactions: D:L.332, D:L.332, D:I.335, D:Y.336, D:Y.339, D:Y.339, D:V.391, D:I.394, D:I.398, D:I.399, D:V.402, D:F.425, D:I.429, D:Y.467, D:Y.467
- Hydrogen bonds: D:F.425
- Salt bridges: D:H.426, D:H.426, D:R.470
Y01.30: 20 residues within 4Å:- Chain A: M.554, I.557, T.558, A.561, I.565
- Chain D: P.424, F.425, L.428, S.455, F.456, V.459, L.460, C.463, R.470, T.479, I.480, I.482, Q.483, I.486, Q.596
16 PLIP interactions:13 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: D:P.424, D:F.425, D:L.428, D:F.456, D:F.456, D:V.459, D:V.459, D:I.482, D:Q.483, D:I.486, A:I.557, A:A.561, A:I.565
- Hydrogen bonds: D:T.479, D:Q.596
- Salt bridges: D:R.470
Y01.31: 11 residues within 4Å:- Chain A: S.556, A.560, I.564
- Chain D: C.494, M.497, P.527, M.528, L.530, F.531, F.534
- Ligands: POV.33
7 PLIP interactions:5 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:L.530, D:F.531, D:F.531, D:F.534, D:F.534, A:A.560, A:I.564
- 16 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.5: 6 residues within 4Å:- Chain A: M.435, M.442, G.449, V.452, P.453
- Chain B: F.553
Ligand excluded by PLIPPOV.6: 18 residues within 4Å:- Chain A: C.494, W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527, L.530
- Chain D: I.341, M.345, I.348, Y.349, W.462, V.465
- Ligands: Y01.4, ECL.28
Ligand excluded by PLIPPOV.7: 11 residues within 4Å:- Chain A: C.346, C.347, L.373, Y.377, L.386, E.389, V.393, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.8: 8 residues within 4Å:- Chain A: C.342, M.345, C.346, Y.349, K.381, I.384, R.385, G.388
Ligand excluded by PLIPPOV.15: 6 residues within 4Å:- Chain B: M.435, M.442, G.449, V.452, P.453
- Chain C: F.553
Ligand excluded by PLIPPOV.16: 18 residues within 4Å:- Chain A: I.341, M.345, I.348, Y.349, W.462, V.465
- Chain B: C.494, W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527, L.530
- Ligands: ECL.1, Y01.14
Ligand excluded by PLIPPOV.17: 11 residues within 4Å:- Chain B: C.346, C.347, L.373, Y.377, L.386, E.389, V.393, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.18: 8 residues within 4Å:- Chain B: C.342, M.345, C.346, Y.349, K.381, I.384, R.385, G.388
Ligand excluded by PLIPPOV.23: 6 residues within 4Å:- Chain C: M.435, M.442, G.449, V.452, P.453
- Chain D: F.553
Ligand excluded by PLIPPOV.24: 18 residues within 4Å:- Chain B: I.341, M.345, I.348, Y.349, W.462, V.465
- Chain C: C.494, W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527, L.530
- Ligands: ECL.11, Y01.22
Ligand excluded by PLIPPOV.25: 11 residues within 4Å:- Chain C: C.346, C.347, L.373, Y.377, L.386, E.389, V.393, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.26: 8 residues within 4Å:- Chain C: C.342, M.345, C.346, Y.349, K.381, I.384, R.385, G.388
Ligand excluded by PLIPPOV.27: 8 residues within 4Å:- Chain D: C.342, M.345, C.346, Y.349, K.381, I.384, R.385, G.388
Ligand excluded by PLIPPOV.32: 6 residues within 4Å:- Chain A: F.553
- Chain D: M.435, M.442, G.449, V.452, P.453
Ligand excluded by PLIPPOV.33: 18 residues within 4Å:- Chain C: I.341, M.345, I.348, Y.349, W.462, V.465
- Chain D: C.494, W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527, L.530
- Ligands: ECL.19, Y01.31
Ligand excluded by PLIPPOV.34: 11 residues within 4Å:- Chain D: C.346, C.347, L.373, Y.377, L.386, E.389, V.393, T.439, R.443, L.444, M.454
Ligand excluded by PLIP- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ECL: 1-[(2R)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole(Non-covalent)
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 16 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.